Post by
ohwhatanight on Mar 26, 2016 5:56pm
Cash on hand
Don't forget $155m was as of December 31st .. they are generating $25 my each month clear. They should have $230m by now. They could pay off off both bridge loans of $133m costing 9.5%
Throwing an extra $13m onto bottom line. Distancing ourselves from VRX
Comment by
COGT on Mar 26, 2016 8:26pm
They quietly telegraphed that if you can read between the lines .That will be the next news event IMHO Regardless there are a number of USA pharma looking for more off shore exposure to off set the threat of Clinton et al CXR will get taken out before long and the debt is a non issue with the giants in pharma IMHO
Comment by
COGT on Mar 26, 2016 11:58pm
Lattice grit your teeth and short because #'s are out for ALL to see .....In the short term big guys will do the dd in "we can plug this ...plug that ...."but this is not a bleeding machine eyes have been here keenly awaiting post acquisition Debt being paid and low share price puts Cxr in line for a big thank you from suitor TBA
Comment by
Lattice on Mar 27, 2016 12:46am
This post has been removed in accordance with Community Policy
Comment by
Pj1958 on Mar 27, 2016 1:51am
Lettuce.... The only one with a disease is you, and you might need some of the psychotic meds that CXR is selling... It will add to our bottom line.